Most Recent
Class action filed against BHP Billiton over Brazil dam disaster
BHP has been hit with a shareholder class action over the deadly Samarco mine disaster that wiped off $25 billion from the share price of the mining giant.
Asiago cheese needn’t come from Italy, IP Australia rules
IP Australia has ruled in part that cheese branded with the Asiago label need not be manufactured in the Asiago region in Italy, striking down an opposition to a trade mark filed by cheese producer Sartori Company.
Wyeth says generic Effexor registration ‘not legitimate’
Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, pharmaceutical giant Wyeth told a judge on day two of a six-week trial over its blockbuster antidepressant.
Ex-Citi, Deutsche CEOs among 6 charged over alleged ANZ cartel
High-ranking bank officials, including the former CEOs of Citigroup and Deutsche Bank in Australia, are among the executives charged over a cartel involving a $2.5 billion ANZ institutional share placement.
Judge adds Google LLC to injunction in Unlockd case
The judge overseeing a competition case against Google by mobile advertising startup Unlockd has extended a temporary injunction to the search engine giant's US arm.
VW wants Bannister Law class actions shut down
The fate of class actions against Volkswagen in the sprawling Australian case over the car maker's diesel emissions cheating scandal will be the subject of a major court battle starting Wednesday.
Glenville wins appeal of privilege ruling in Amcor asbestos dispute
Luxury home builder Glenville has won an appeal of a ruling that shielded certain documents from production by legal professional privilege in a lawsuit against global packaging giant Amcor over liability for asbestos remediation at a former Amcor paper mill site in a Melbourne suburb.
High Court lets stand Pfizer’s early discovery win
The High Court has rejected a bid by biopharmaceutical company Samsung Bioepis Australia to challenge a ruling granting Pfizer preliminary discovery for a potential patent infringement case over autoimmune drug Enbrel.
Wyeth launches “ambush” at start of Effexor trial, court told
Pharmaceutical giant Wyeth's has launched an "ambush" at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
Garmin denied quick win in $1.1M dispute
A judge has denied a bid for summary judgment by Garmin Australia in a lawsuit brought by the GPS giant seeking $1.1 million allegedly owed under an agreement to supply its products for sale in Australia.